Some researchers reported a role of SF3B1 mutations in myelofibrotic progression in patients with polycythemia vera and essential thrombocythemia [15], whereas others concluded that SF3B1 mutations did not correlate with fibrotic evolution [16]. The gene discussed is SF3B1; the disease is acquired polycythemia vera.